uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Comparison of [177Lu-DOTA0,Tyr3]-Octreotate and [177Lu-DOTA0,Tyr3]-Octreotide for Receptor-Mediated Radiation Therapy of the Xenografted Human Midgut Carcinoid Tumor GOT1
Show others and affiliations
2008 (English)In: Cancer Biotherapy and Radiopharmaceuticals, ISSN 1084-9785, E-ISSN 1557-8852, Vol. 23, no 1, 114-120 p.Article in journal (Refereed) Published
Abstract [en]

The aim of this study was to compare the tumor uptake versus time and the tumor response in nude mice transplanted with a human midgut carcinoid (GOT1), when treated with either [177Lu-DOTA0,Tyr3]-octreotide or [177Lu-DOTA0,Tyr3]-octreotate and to evaluate if plasma chromogranin A (P-CgA) was a reliable marker of tumor response. The tumor uptake and retention of activity of a single intravenous (i.v.) dose (15 MBq) of [177Lu-DOTA0,Tyr3]-octreotate or [177Lu-DOTA0,Tyr3]-octreotide were compared in nude mice xenografted with GOT1. The activity concentration 24 hours after injection was significantly higher in animals given [177Lu-DOTA0,Tyr3]-octreotate versus [177Lu-DOTA0,Tyr3]-octreotide (16% ± 1.4% of injected activity per gram [%IA/g] vs. 8.1% ± 2.1% IA/g, mean ± standard error of the mean) (p = 0.00061). The mean absorbed dose was higher in animals given [177Lu-DOTA0,Tyr3]-octreotate (46 ± 4.3 vs. 17 ± 3.4 Gy). The reduction of tumor volume was accordingly more prominent in animals given [177Lu-DOTA0,Tyr3]-octreotate than in animals given [177Lu-DOTA0,Tyr3]-octreotide (p = 0.003). The mean tumor volume for animals given [177Lu-DOTA0,Tyr3]-octreotate was reduced to 3% of its initial value. P-CgA values were strongly correlated with tumor volume. Octreotate seems to be a more suitable somatostatin analog than octreotide for receptor-mediated radiation therapy. P-CgA is a simple, accurate method for the estimation of tumor response in this animal model.

Place, publisher, year, edition, pages
2008. Vol. 23, no 1, 114-120 p.
Keyword [en]
octreotate, octreotide, somatostatin receptor, carcinoid, chromogranin A
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-152597DOI: 10.1089/cbr.2007.0421ISI: 000254025100012OAI: oai:DiVA.org:uu-152597DiVA: diva2:413531
Available from: 2011-04-28 Created: 2011-04-28 Last updated: 2017-12-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Stridsberg, Mats

Search in DiVA

By author/editor
Stridsberg, Mats
By organisation
Biochemical endocrinology
In the same journal
Cancer Biotherapy and Radiopharmaceuticals
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 382 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf